346 related articles for article (PubMed ID: 16103361)
1. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal.
Abu-Elheiga L; Matzuk MM; Kordari P; Oh W; Shaikenov T; Gu Z; Wakil SJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12011-6. PubMed ID: 16103361
[TBL] [Abstract][Full Text] [Related]
2. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.
Harada N; Oda Z; Hara Y; Fujinami K; Okawa M; Ohbuchi K; Yonemoto M; Ikeda Y; Ohwaki K; Aragane K; Tamai Y; Kusunoki J
Mol Cell Biol; 2007 Mar; 27(5):1881-8. PubMed ID: 17210641
[TBL] [Abstract][Full Text] [Related]
3. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
Abu-Elheiga L; Matzuk MM; Abo-Hashema KA; Wakil SJ
Science; 2001 Mar; 291(5513):2613-6. PubMed ID: 11283375
[TBL] [Abstract][Full Text] [Related]
4. Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice.
Oh W; Abu-Elheiga L; Kordari P; Gu Z; Shaikenov T; Chirala SS; Wakil SJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1384-9. PubMed ID: 15677334
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle ACC2 S212 phosphorylation is not required for the control of fatty acid oxidation during exercise.
O'Neill HM; Lally JS; Galic S; Pulinilkunnil T; Ford RJ; Dyck JR; van Denderen BJ; Kemp BE; Steinberg GR
Physiol Rep; 2015 Jul; 3(7):. PubMed ID: 26156967
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of acetyl-CoA carboxylases by soraphen A prevents lipid accumulation and adipocyte differentiation in 3T3-L1 cells.
Cordonier EL; Jarecke SK; Hollinger FE; Zempleni J
Eur J Pharmacol; 2016 Jun; 780():202-8. PubMed ID: 27041646
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription.
Zhao LF; Iwasaki Y; Zhe W; Nishiyama M; Taguchi T; Tsugita M; Kambayashi M; Hashimoto K; Terada Y
Endocr J; 2010; 57(4):317-24. PubMed ID: 20139635
[TBL] [Abstract][Full Text] [Related]
8.
Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
Front Immunol; 2018; 9():495. PubMed ID: 29675017
[No Abstract] [Full Text] [Related]
9. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis.
Mao J; DeMayo FJ; Li H; Abu-Elheiga L; Gu Z; Shaikenov TE; Kordari P; Chirala SS; Heird WC; Wakil SJ
Proc Natl Acad Sci U S A; 2006 May; 103(22):8552-7. PubMed ID: 16717184
[TBL] [Abstract][Full Text] [Related]
10. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
11. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets.
Abu-Elheiga L; Oh W; Kordari P; Wakil SJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10207-12. PubMed ID: 12920182
[TBL] [Abstract][Full Text] [Related]
12. Improving production of malonyl coenzyme A-derived metabolites by abolishing Snf1-dependent regulation of Acc1.
Shi S; Chen Y; Siewers V; Nielsen J
mBio; 2014 May; 5(3):e01130-14. PubMed ID: 24803522
[TBL] [Abstract][Full Text] [Related]
13. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.
Savage DB; Choi CS; Samuel VT; Liu ZX; Zhang D; Wang A; Zhang XM; Cline GW; Yu XX; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Clin Invest; 2006 Mar; 116(3):817-24. PubMed ID: 16485039
[TBL] [Abstract][Full Text] [Related]
14. ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus [corrected].
Castle JC; Hara Y; Raymond CK; Garrett-Engele P; Ohwaki K; Kan Z; Kusunoki J; Johnson JM
PLoS One; 2009; 4(2):e4369. PubMed ID: 19190759
[TBL] [Abstract][Full Text] [Related]
15. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
[TBL] [Abstract][Full Text] [Related]
16. AMPK-dependent inhibitory phosphorylation of ACC is not essential for maintaining myocardial fatty acid oxidation.
Zordoky BN; Nagendran J; Pulinilkunnil T; Kienesberger PC; Masson G; Waller TJ; Kemp BE; Steinberg GR; Dyck JR
Circ Res; 2014 Aug; 115(5):518-24. PubMed ID: 25001074
[TBL] [Abstract][Full Text] [Related]
17. Yeast mutants defective in acetyl-coenzyme A carboxylase and biotin: apocarboxylase ligase.
Mishina M; Roggenkamp R; Schweizer E
Eur J Biochem; 1980 Oct; 111(1):79-87. PubMed ID: 6108218
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of acetyl-CoA carboxylase 2 enhances skeletal muscle fatty acid oxidation and improves whole-body glucose homeostasis in db/db mice.
Glund S; Schoelch C; Thomas L; Niessen HG; Stiller D; Roth GJ; Neubauer H
Diabetologia; 2012 Jul; 55(7):2044-53. PubMed ID: 22532389
[TBL] [Abstract][Full Text] [Related]
19. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.
Dzamko N; Schertzer JD; Ryall JG; Steel R; Macaulay SL; Wee S; Chen ZP; Michell BJ; Oakhill JS; Watt MJ; Jørgensen SB; Lynch GS; Kemp BE; Steinberg GR
J Physiol; 2008 Dec; 586(23):5819-31. PubMed ID: 18845612
[TBL] [Abstract][Full Text] [Related]
20. Acetyl-CoA Carboxylases and Diseases.
Wang Y; Yu W; Li S; Guo D; He J; Wang Y
Front Oncol; 2022; 12():836058. PubMed ID: 35359351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
